Follicular hyperplasia Exercise Germinal centers Myoblasts Autoimmune diseases Etiology Inflammation Cell-cell communication Myasthenia Gravis MG Fragile X syndromes Interferon IFN Il-23 Ectopic germinal centers Auto-immunité Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Quality of life Immune regulation Gd T cells Interleukin 23 Neuromuscular junction Chronicity Interleukine-23 Experimental mouse models Adaptive immunity Complete Freund's adjuvant Interferon type I Interferon-β Acides nucléiques endogènes CCL21 CTCF Genetics Glucocorticoids Autoimmunity Interferon PBMC Chronic inflammation Experimental autoimmune myasthenia gravis Immunology and Microbiology Section Autoimmune disease Conduction disease Centres germinatifs ectopiques CXCL13-CXCR5 Experimental autoimmune myasthenia gravis EAMG Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Immunity Early-onset myasthenia gravis Ferrites Myasthenia Gravis Gender Cytokines Endogenous nucleic acids Cellules th17 Acetylcholine receptor Interferon de type I COX2 DICER M3243AG LMNA Transcriptome Interferon type-I Chemokines Germinal center Acetylcholine receptor antibodies Interféron de type I Th17 cells Chemokine Inflammatory cytokines Myasthénie grave COVID-19 Innate immunity B cells Antimir-150 Acetylcholine receptors Thymectomy MND Immune response Clinical cell transplantation CD31 Interferonopathy Disease susceptibility Lamin A/C nuclei Experimental models Human myoblasts Immunotherapy MG patients Assay comparison Heart failure Long-term follow-up Animal models BAFF FMR1 Age Cardiomyopathy Thymic epithelial cells Thymoma Thymus Genetic associations Anticorps monoclonal AChR antibodies Myasthenia gravis